+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biologic Therapeutics Market 2020-2024 - Product Image

Global Biologic Therapeutics Market 2020-2024

  • ID: 5143069
  • Report
  • August 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • MORE
The global biologic therapeutics market is poised to grow by $190.94 bn during 2020-2024 progressing at a CAGR of 12% during the forecast period.

This report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the strong R&D pipeline, targeted therapeutic mechanism of biologics, and increasing investment in development of biologics. In addition, strong R&D pipeline is anticipated to boost the growth of the market as well.

The biologic therapeutics market analysis includes product segment and geographical landscapes.

The global biologic therapeutics market is segmented as below:

By Product
  • Antibody therapeutics
  • Vaccines
  • Cell therapy
  • Gene therapy
  • Other therapies
By Geography
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the introduction of biosimilars as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, increasing incidence of chronic diseases and immunological disorders and patent expiry of major biologics will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The report covers the following areas:
  • Biologic therapeutics market sizing
  • Biologic therapeutics market forecast
  • Biologic therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019-2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Antibody therapeutics - Market size and forecast 2019-2024
  • Vaccines - Market size and forecast 2019-2024
  • Cell therapy - Market size and forecast 2019-2024
  • Gene therapy - Market size and forecast 2019-2024
  • Other therapies - Market size and forecast 2019-2024
  • Market opportunity by Product
Market segmentation by application
  • Oncology
  • Autoimmune and inflammatory diseases
  • Hematology
  • Other applications
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2019-2024 ($ billion)
14: Global market: Year-over-year growth 2019-2024 (%)
15: Five forces analysis 2019 & 2024
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2019
22: Product - Market share 2019-2024 (%)
23: Comparison by Product
24: Antibody therapeutics - Market size and forecast 2019-2024 ($ billion)
25: Antibody therapeutics - Year-over-year growth 2019-2024 (%)
26: Vaccines - Market size and forecast 2019-2024 ($ billion)
27: Vaccines - Year-over-year growth 2019-2024 (%)
28: Cell therapy - Market size and forecast 2019-2024 ($ billion)
29: Cell therapy - Year-over-year growth 2019-2024 (%)
30: Gene therapy - Market size and forecast 2019-2024 ($ billion)
31: Gene therapy - Year-over-year growth 2019-2024 (%)
32: Other therapies - Market size and forecast 2019-2024 ($ billion)
33: Other therapies - Year-over-year growth 2019-2024 (%)
34: Market opportunity by Product
35: Application - Market share 2019-2024 (%)
36: Comparison by Application
37: Market opportunity by Application
38: Customer Landscape
39: Market share by geography 2019-2024 (%)
40: Geographic comparison
41: North America - Market size and forecast 2019-2024 ($ billion)
42: North America - Year-over-year growth 2019-2024 (%)
43: Europe - Market size and forecast 2019-2024 ($ billion)
44: Europe - Year-over-year growth 2019-2024 (%)
45: Asia - Market size and forecast 2019-2024 ($ billion)
46: Asia - Year-over-year growth 2019-2024 (%)
47: ROW - Market size and forecast 2019-2024 ($ billion)
48: ROW - Year-over-year growth 2019-2024 (%)
49: Key leading countries
50: Market opportunity by geography ($ billion)
51: Impact of drivers and challenges
52: Vendor landscape
53: Landscape disruption
54: Industry risks
55: Vendors covered
56: Market positioning of vendors
57: AbbVie Inc. - Overview
58: AbbVie Inc. - Business segments
59: AbbVie Inc. - Key offerings
60: AbbVie Inc. - Key customers
61: AbbVie Inc. - Segment focus
62: AstraZeneca Plc - Overview
63: AstraZeneca Plc - Product and service
64: AstraZeneca Plc - Key offerings
65: AstraZeneca Plc - Key customers
66: AstraZeneca Plc - Segment focus
67: Bristol-Myers Squibb Co. - Overview
68: Bristol-Myers Squibb Co. - Product and service
69: Bristol-Myers Squibb Co. - Key offerings
70: Bristol-Myers Squibb Co. - Key customers
71: Bristol-Myers Squibb Co. - Segment focus
72: F. Hoffmann-La Roche Ltd. - Overview
73: F. Hoffmann-La Roche Ltd. - Business segments
74: F. Hoffmann-La Roche Ltd. - Key offerings
75: F. Hoffmann-La Roche Ltd. - Key customers
76: F. Hoffmann-La Roche Ltd. - Segment focus
77: GlaxoSmithKline Plc - Overview
78: GlaxoSmithKline Plc - Business segments
79: GlaxoSmithKline Plc - Key offerings
80: GlaxoSmithKline Plc - Key customers
81: GlaxoSmithKline Plc - Segment focus
82: Johnson & Johnson - Overview
83: Johnson & Johnson - Business segments
84: Johnson & Johnson - Key offerings
85: Johnson & Johnson - Key customers
86: Johnson & Johnson - Segment focus
87: Merck & Co. Inc. - Overview
88: Merck & Co. Inc. - Business segments
89: Merck & Co. Inc. - Key offerings
90: Merck & Co. Inc. - Key customers
91: Merck & Co. Inc. - Segment focus
92: Novartis AG - Overview
93: Novartis AG - Business segments
94: Novartis AG - Key offerings
95: Novartis AG - Key customers
96: Novartis AG - Segment focus
97: Pfizer Inc. - Overview
98: Pfizer Inc. - Business segments
99: Pfizer Inc. - Key offerings
100: Pfizer Inc. - Key customers
101: Pfizer Inc. - Segment focus
102: Sanofi - Overview
103: Sanofi - Business segments
104: Sanofi - Key offerings
105: Sanofi - Key customers
106: Sanofi - Segment focus
107: Currency conversion rates for US$
108: Research Methodology
109: Validation techniques employed for market sizing
110: Information sources
111: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • MORE
The publisher recognizes the following companies as the key players in the global biologic therapeutics market: AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst said: According to the report, one of the major drivers for this market is the strong R&D pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll